CTOs on the Move

Versartis

www.versartis.com

 
Versartis, Inc. (NASDAQ: VSAR) is an endocrine-focused biopharmaceutical company developing novel, long-acting medicines to transform treatment for patients with endocrine disorders. The company is led by a management team with rich experience and expertise discovering, developing and commercializing innovative therapeutics for the life sciences industry. Versartis` mission is to develop, manufacture and commercialize novel therapeutics to improve and transform treatment for patients with orphan endocrine disorders. Versartis is well-positioned to deliver a major innovation to the global growth hormone deficiency (GHD) market with the company`s most advanced clinical candidate, somavaratan. Somavaratan is a novel, long-acting form ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
Todd Dekkinga
 Vice President of Information Technology Profile

Similar Companies

Alfie

Alfie uses precision tests to determine the right combination of prescription medication and 1:1 health coaching to optimize your weight loss.

AmerisourceBergen Technology Group

AmerisourceBergen Technology Group is a Wayne, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Technology Commercialization Group

Technology Commercialization Group is a Durham, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Before Brands Inc

Before Brands is a health and wellness company that is developing a series of products targeted at transforming the world`s relationship with food allergies. The science behind each of our products is our proprietary Early Adaptive Training (E.A.T.) protein blend that was developed at Stanford University by a pediatrician, allergist and Mother of five.

National Kidney Registry

The National Kidney Registry is a national registry in the United States listing kidney donors and recipients in need of a kidney transplant.